Tag: Cancer: Breast
State Insurance Legislation May Improve Breast Cancer Diagnosis
Legislation mandating insurance coverage for breast cancer screening more impactful than breast density notification
Breast Cancer Screening Down Among Low-Income Women During Pandemic
Eight percent drop in screenings at 32 community health centers means about 47,517 fewer mammograms, 242 missed breast cancer diagnoses
Breast Density Linked to Risk for Invasive Breast Cancer in ≥65s
Risk for invasive breast cancer increased with increasing breast density for women aged 65 to 74 years, 75 years or older
Screening Mammograms Plummeted During COVID-19 Pandemic
Drop in breast cancer screenings at one safety-net hospital raises concerns for worsening of preexisting health disparities
Model Predicts False-Positives in Breast Cancer MRI Screen
Full prediction model could prevent 45.5 percent of false-positive recalls, 21.3 percent of benign biopsies for those with extremely dense breasts
Genetic Testing Proposed for Women Diagnosed With Breast Cancer at Age 65+
Mutations in actionable breast cancer risk genes present in 3.2 percent of older women with breast cancer
Statin Use Improves Survival in Triple-Negative Breast Cancer
Overall survival, breast cancer-specific survival improved among women with TNBC, but not those without TNBC
Five-Year Extended Hormone Therapy No Better in Breast Cancer
Findings compared with two years of extended adjuvant anastrozole in postmenopausal women with hormone-receptor-positive breast cancer
No Benefit Seen From Adjuvant Celecoxib in ERBB2-Negative Breast Cancer
Disease-free survival did not improve with two years of celecoxib versus placebo in ERBB2-negative breast cancer
Impact of Pandemic Projected for U.S. Breast Cancer Mortality
Cumulative increase of 0.52 percent expected in breast cancer deaths by 2030 due to disruptions during the first six months of the pandemic
